Searched for
BIOCON STOCK BUY
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...- Bank Nifty near key resistance zone; breakout above 54,300 crucial: Ajit MishraIndian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank Nifty showing relative streng...
- The 20 stocks mutual funds are buying with Rs 1 lakh crore to defy historic FII sellingIndian mutual funds are investing Rs 1.07 lakh crore in 20 key stocks to counter historic FII selling. They are focusing on large-cap priva...
- Ahead of Market: 10 things that will decide stock market action on ThursdayBenchmark indices closed marginally higher on Wednesday, led by gains in banking and auto shares, while IT and FMCG stocks capped advances....
- Ahead of Market: 10 things that will decide D-Street action on MondayNifty broke below its 23,800–24,500 consolidation range, signalling near-term weakness, with resistance now seen at 23,800–24,000 and key s...
- Jio Financial, ITC Hotels and Manappuram Finance among stocks bought and sold by mutual funds in AprilMutual funds injected Rs 30,600 crore into Indian equities in April, with significant buying in ICICI Bank, SBI, and Sun Pharma. Key reduct...
- Two Trades for Today: A biopharma firm for a 7.65% rise, a mid-cap healthcare stock for an upmove of about 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- I-Sec maintains Sell on Biocon, revises target price to Rs 270ICICI Securities maintains a 'Sell' call on Biocon, setting a revised target price of Rs 270. Despite a projected earnings CAGR of 91.6% dr...
- Buy Biocon, target price Rs 351: Axis SecuritiesAxis Securities recommends a Buy call on Biocon, setting a target price of Rs 351, indicating a potential 10% upside. The recommendation is...
- Buy Biocon, target price Rs 266: Sharekhan by BNP ParibasBiocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 26389.19 Crore) operating in Pharmaceuticals secto...
- Buy Biocon, target price Rs 365: JM FinancialGiven the multiple near-term levers, enviable biosimilars pipeline, strengthening of leadership teams, favourable valuation and marquee inv...
- Buy Biocon, target price Rs 375: JM FinancialBiocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 28934.46 Crore) operating in Pharmaceuticals secto...
- Buy Biocon, target price Rs 395: JM FinancialFor the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 2217.40 crore, down 10.45 per cent from las...
- Buy Biocon with target price of Rs 414: Sandeep WagleBuy Biocon with a stop loss of Rs 399 for target of Rs 414.
- Buy Biocon Ltd with target price of Rs 400: Mitesh ThackerBiocon Ltd is a ‘Buy’ with a target of Rs 400 and a stop loss of Rs 377.
- Buy Biocon with target price of Rs 396: Sandeep WagleBiocon is a ‘Buy’ with a target of Rs 396 and a stop loss of Rs 363.
- Buy Biocon with target price of Rs 388: Sandeep WagleBiocon is a ‘Buy’ with a target of Rs 388 and a stop loss of Rs 367.
- Buy Biocon Ltd with target price of Rs 360: Mitesh ThackerBiocon Ltd is a 'Buy' with a target of Rs 360 and a stop loss of Rs 338.
Load More
